Ginkgo Bioworks Holdings Inc Class (DNA)
EBITDA Growth
3.73%
Quarterly · Period ending:
DNA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported3.73%period ending
Latest reported3.73%period ending
DNA Quarterly EBITDA YoY % (-449.96% → 3.73%)
Year-over-year change
High-resolution chart · PNG
DNA ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 3.7288% | |
| 7.3014% | |
| 52.7954% | |
| -89.7794% | |
| 67.2516% | |
| 55.3437% | |
| 50.511% | |
| 79.2542% | |
| 9.5793% | |
| 17.7046% | |
| -121.2741% | |
| 74.4234% | |
| 76.4457% | |
| 68.1323% | |
| 91.796% | |
| -605.8217% | |
| -1,298.0001% | |
| -747.6167% | |
| -2,978.2592% | |
| -325.817% | |
| -69.5017% | |
| -449.9601% |